I think that once Mounjaro is approved for weight loss at the end of 2023 this trend will gain steam in a significant way, which would likely reflect in Q2-Q3 2024 earnings for PHG, RMD etc
Decisions regarding therapy resumption should involve a careful risk-benefit discussion with a qualified healthcare professional
Any muscle-related benefit is likely indirect, through faster recovery between sessions rather than a direct anabolic effect
Diabetes Metab (2020) 46(5):35361
On the other hand, the microbiome houses many genera of bacteria that fail to grow in the absence of thiamine (59), and depend on its external sources (60)
Exenatide, liraglutide, dulaglutide, and semaglutide demonstrated significant associations with these 19 NAE signals, whereas lixisenatide and tirzepatide showed no significant associations